InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Wednesday, 08/17/2016 9:25:19 AM

Wednesday, August 17, 2016 9:25:19 AM

Post# of 48316
OncoSec Presents Positive Melanoma Clinical Data at American Association for Cancer Research (AACR) Annual Meeting 2016

This was the data release on April 19th in which a subset of 8 patients had a %75 response rate to EP-IL12 and Pembrolizumab. Anybody know if these patients were screened using the UCSF Biomarker test? Were they non-responders is what I am wondering.